Evidence map›Paper›PMID 39399866›Full record

ReviewThe Lancet regional health. Western Pacific2024

Regional health priorities for dementia: a roadmap for the Western Pacific.

Hannah C Timmins, Vincent C T Mok, Seung Hyun Kim, Nortina Shahrizaila, Jia-Ying Sung, Gen Sobue, Sheila Agustini, Stephanie Ward, Kaarin J Anstey, Dayna-Lee Talbot and 14 more

Abstract readReview
In one paragraph

Review in The Lancet regional health. Western Pacific, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Hannah C TimminsNeuroscience Research Australia, Sydney, Australia.
Vincent C T MokGerald Choa Neuroscience Institute, Lau Tat Chuen Research Centre of Brain Degenerative Diseases in Chinese, Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Seung Hyun KimDepartment of Neurology, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
Nortina ShahrizailaNeurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Jia-Ying SungDepartment of Neurology, School of Medicine, Taipei Medical University, Taiwan.
Gen SobueAichi Medical University, Nagakute, Aichi 480-1195, Japan.
Sheila AgustiniMayapada Hospital, Jakarta Selatan, Indonesia.
Stephanie WardCentre for Healthy Brain Ageing, School of Psychiatry, The University of New South Wales, Sydney, Australia.
Kaarin J AnsteyNeuroscience Research Australia, Sydney, Australia.
Dayna-Lee TalbotNeuroscience Research Australia, Sydney, Australia.
Srestha MazumderNeuroscience Research Australia, Sydney, Australia.
Sicong TuNeuroscience Research Australia, Sydney, Australia.
Rachel H TanBrain and Mind Centre, University of Sydney, Sydney, Australia.
Cindy Shin-Yi LinBrain and Mind Centre, University of Sydney, Sydney, Australia.
Claire O'CallaghanBrain and Mind Centre, University of Sydney, Sydney, Australia.
Johannes C MichaelianBrain and Mind Centre, University of Sydney, Sydney, Australia.
Yun-Hee JeonSusan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
David FoxeBrain and Mind Centre, University of Sydney, Sydney, Australia.
Sharon L NaismithBrain and Mind Centre, University of Sydney, Sydney, Australia.
Olivier PiguetBrain and Mind Centre, University of Sydney, Sydney, Australia.
Rebekah AhmedBrain and Mind Centre, University of Sydney, Sydney, Australia.
Emma DevenneyNeuroscience Research Australia, Sydney, Australia.
Susanna B ParkBrain and Mind Centre, University of Sydney, Sydney, Australia.
Matthew C KiernanNeuroscience Research Australia, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Western Pacific Region, the prevalence of dementia is expected to increase, however, the diversity of the region is expected to present unique challenges. The region has varying levels of preparedness, with a limited number of countries having a specific national dementia plan and awareness campaigns. Diversity of risk and healthcare services within the region is exerting impact on diagnosis, treatment, care, and support, with most countries being under resourced. Similarly, the ability to monitor dementia-related indicators and progress research, particularly relating to treatment and clinical trial access needs to be addressed. Countries require comprehensive national plans that lay out how resources will be allocated to improve dementia literacy, train, and support carers, mobilise resources to reduce risk factors and improve research capabilities. These plans need to be informed by consumers and tailored to the region to develop an inclusive society for people living with dementia and their families.

Indexed as

Alzheimer’s diseaseDementiaHealth policyWestern pacific region

Identifiers

PMID39399866
PMCPMC11471056

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.